A detailed history of Ubs Group Ag transactions in Mannkind Corp stock. As of the latest transaction made, Ubs Group Ag holds 653,489 shares of MNKD stock, worth $4.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
653,489
Previous 474,974 37.58%
Holding current value
$4.46 Million
Previous $2.48 Million 65.51%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $894,360 - $1.2 Million
178,515 Added 37.58%
653,489 $4.1 Million
Q2 2024

Aug 13, 2024

SELL
$4.05 - $5.43 $831,841 - $1.12 Million
-205,393 Reduced 30.19%
474,974 $2.48 Million
Q1 2024

May 13, 2024

SELL
$3.25 - $5.27 $120,627 - $195,601
-37,116 Reduced 5.17%
680,367 $3.08 Million
Q4 2023

Feb 09, 2024

BUY
$3.34 - $4.29 $1.29 Million - $1.66 Million
386,868 Added 117.01%
717,483 $2.61 Million
Q3 2023

Nov 09, 2023

SELL
$3.91 - $5.45 $399,723 - $557,158
-102,231 Reduced 23.62%
330,615 $1.37 Million
Q2 2023

Aug 11, 2023

SELL
$3.72 - $4.79 $382,140 - $492,057
-102,726 Reduced 19.18%
432,846 $1.76 Million
Q1 2023

May 12, 2023

SELL
$3.95 - $5.63 $1.44 Million - $2.06 Million
-365,822 Reduced 40.58%
535,572 $2.2 Million
Q4 2022

Feb 08, 2023

BUY
$3.02 - $5.37 $2.04 Million - $3.62 Million
674,505 Added 297.28%
901,394 $4.75 Million
Q3 2022

Nov 10, 2022

SELL
$2.99 - $4.35 $26,021 - $37,858
-8,703 Reduced 3.69%
226,889 $701,000
Q2 2022

Aug 10, 2022

SELL
$2.67 - $4.77 $1.68 Million - $2.99 Million
-627,515 Reduced 72.7%
235,592 $897,000
Q1 2022

May 16, 2022

BUY
$2.62 - $4.45 $321,895 - $546,731
122,861 Added 16.6%
863,107 $3.18 Million
Q4 2021

Feb 14, 2022

BUY
$4.05 - $5.37 $874,119 - $1.16 Million
215,832 Added 41.16%
740,246 $3.24 Million
Q3 2021

Nov 15, 2021

BUY
$3.89 - $5.48 $1.64 Million - $2.3 Million
420,611 Added 405.2%
524,414 $2.28 Million
Q2 2021

Aug 13, 2021

SELL
$3.61 - $5.45 $1.1 Million - $1.65 Million
-303,468 Reduced 74.51%
103,803 $566,000
Q1 2021

May 12, 2021

BUY
$3.14 - $6.14 $1.19 Million - $2.33 Million
379,150 Added 1348.28%
407,271 $1.6 Million
Q4 2020

Feb 11, 2021

BUY
$1.79 - $4.04 $302 - $682
169 Added 0.6%
28,121 $88,000
Q3 2020

Nov 12, 2020

SELL
$1.56 - $2.08 $10,849 - $14,466
-6,955 Reduced 19.92%
27,952 $52,000
Q2 2020

Jul 31, 2020

BUY
$0.94 - $2.21 $5,110 - $12,015
5,437 Added 18.45%
34,907 $61,000
Q1 2020

May 01, 2020

BUY
$0.84 - $1.76 $9,657 - $20,234
11,497 Added 63.97%
29,470 $31,000
Q4 2019

Feb 14, 2020

BUY
$1.14 - $1.49 $15,959 - $20,860
14,000 Added 352.38%
17,973 $23,000
Q3 2019

Nov 14, 2019

SELL
$1.04 - $1.44 $13,996 - $19,379
-13,458 Reduced 77.21%
3,973 $5,000
Q2 2019

Aug 14, 2019

SELL
$1.09 - $1.88 $23,872 - $41,173
-21,901 Reduced 55.68%
17,431 $20,000
Q1 2019

May 14, 2019

BUY
$1.14 - $2.25 $24,531 - $48,417
21,519 Added 120.81%
39,332 $77,000
Q4 2018

Feb 14, 2019

SELL
$1.02 - $2.05 $122 - $245
-120 Reduced 0.67%
17,813 $19,000
Q3 2018

Nov 14, 2018

BUY
$1.01 - $2.19 $8,847 - $19,184
8,760 Added 95.5%
17,933 $33,000
Q2 2018

Aug 14, 2018

SELL
$1.59 - $2.38 $8,268 - $12,376
-5,200 Reduced 36.18%
9,173 $17,000
Q1 2018

May 15, 2018

SELL
$2.28 - $3.8 $27,670 - $46,116
-12,136 Reduced 45.78%
14,373 $33,000
Q4 2017

Feb 14, 2018

BUY
$2.28 - $6.71 $27,008 - $79,486
11,846 Added 80.79%
26,509 $61,000
Q3 2017

Nov 14, 2017

SELL
$1.15 - $2.29 $114,175 - $227,358
-99,283 Reduced 87.13%
14,663 $32,000
Q2 2017

Aug 14, 2017

BUY
N/A
82,637 Added 263.94%
113,946 $160,000
Q1 2017

Nov 14, 2017

BUY
N/A
31,309
31,309 $47,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.76B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.